Vireo Growth (VREOF) Amortizatization of Intangibles (2020 - 2026)
Vireo Growth's (VREOF) quarterly Amortizatization of Intangibles came in at $2.7 million in Q1 2026, up 2600.0% year-on-year from $100000.0 in Q1 2025, and up 216.11% quarter-over-quarter from -$2.3 million in Q4 2025.
Vireo Growth (VREOF) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $2.7 million for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $2.7 million, up 2600.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 239.36% YoY), and the FY2025 annual result was $99116.0, down 86.24% from the prior year.
- Amortizatization of Intangibles came in at $2.7 million for Q1 2026 at Vireo Growth, up from -$2.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.7 million in Q1 2026 to a low of -$2.3 million in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $172267.0 (2022), against an average of $405990.8.
- Across the five-year window, Amortizatization of Intangibles plunged 1391.69% in 2025 and surged 2600.0% in 2026, its largest moves.
- Vireo Growth's Amortizatization of Intangibles stood at $159766.0 in 2022, then soared by 507.06% to $969875.0 in 2023, then slumped by 81.44% to $180033.0 in 2024, then slumped by 1391.69% to -$2.3 million in 2025, then surged by 216.11% to $2.7 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.7 million (Q1 2026), -$2.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Vireo Growth | - | - | 59.30 Mn | 2.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | -59,864.00 |
| Jun 30, 2025 | -59,864.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 180,033.00 |
| Dec 31, 2024 | 180,033.00 |
| Sep 30, 2024 | 180,034.00 |
| Sep 30, 2024 | 180,034.00 |
| Jun 30, 2024 | 335,289.00 |
| Jun 30, 2024 | 335,289.00 |
| Mar 31, 2024 | 24,778.00 |
| Mar 31, 2024 | 24,778.00 |
| Dec 31, 2023 | 969,875.00 |
| Dec 31, 2023 | 969,875.00 |